Stocks and Investing Stocks and Investing
Tue, January 14, 2020
Mon, January 13, 2020
Fri, January 10, 2020
Thu, January 9, 2020
Wed, January 8, 2020

Hartaj Singh Maintained (VRTX) at Buy with Increased Target to $265 on, Jan 8th, 2020


Published on 2024-10-26 19:49:05 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $230 to $265 on, Jan 8th, 2020.

Hartaj has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 0 agree with Hartaj's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Hartaj


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Ying Huang of "B of A Securities" Reiterated at Strong Buy with Increased Target to $245 on, Wednesday, November 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019